Literature DB >> 11329852

Angiotensin-converting enzyme inhibitors.

J Menard1, A A Patchett.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11329852     DOI: 10.1016/s0065-3233(01)56002-7

Source DB:  PubMed          Journal:  Adv Protein Chem        ISSN: 0065-3233


× No keyword cloud information.
  13 in total

1.  NCAD, a database integrating the intrinsic conformational preferences of non-coded amino acids.

Authors:  Guillem Revilla-López; Juan Torras; David Curcó; Jordi Casanovas; M Isabel Calaza; David Zanuy; Ana I Jiménez; Carlos Cativiela; Ruth Nussinov; Piotr Grodzinski; Carlos Alemán
Journal:  J Phys Chem B       Date:  2010-06-03       Impact factor: 2.991

2.  Integrating the intrinsic conformational preferences of noncoded α-amino acids modified at the peptide bond into the noncoded amino acids database.

Authors:  Guillem Revilla-López; Francisco Rodríguez-Ropero; David Curcó; Juan Torras; M Isabel Calaza; David Zanuy; Ana I Jiménez; Carlos Cativiela; Ruth Nussinov; Carlos Alemán
Journal:  Proteins       Date:  2011-04-12

Review 3.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

4.  Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.

Authors:  Venkat S R K Yedavalli; Ning Zhang; Hongyi Cai; Peng Zhang; Matthew F Starost; Ramachandra S Hosmane; Kuan-Teh Jeang
Journal:  J Med Chem       Date:  2008-08-05       Impact factor: 7.446

5.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 6.  Role of RNA helicases in HIV-1 replication.

Authors:  Kuan-Teh Jeang; Venkat Yedavalli
Journal:  Nucleic Acids Res       Date:  2006-08-25       Impact factor: 16.971

Review 7.  Viral and cellular RNA helicases as antiviral targets.

Authors:  Ann D Kwong; B Govinda Rao; Kuan-Teh Jeang
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

Review 8.  Ace revisited: a new target for structure-based drug design.

Authors:  K Ravi Acharya; Edward D Sturrock; James F Riordan; Mario R W Ehlers
Journal:  Nat Rev Drug Discov       Date:  2003-11       Impact factor: 84.694

9.  Digoxin suppresses HIV-1 replication by altering viral RNA processing.

Authors:  Raymond W Wong; Ahalya Balachandran; Mario A Ostrowski; Alan Cochrane
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

Review 10.  Cell-surface peptidases.

Authors:  Rolf Mentlein
Journal:  Int Rev Cytol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.